Krzysztof Zeman

Krzysztof Zeman

Auto-generated profile, based on publicly available information

Krzysztof Zeman

Department of Pediatrics, Immunology and Nephrology, Polish Mother's Memorial Hospital–Research Institute, Lodz, Poland

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 June 2011 in Scandinavian Journal of Gastroenterology
Verified
Journal Article
Closed access
PDF file
LBLeokadia Bak-Romaniszyn
Leokadia Bak-Romaniszyn
ASAgnieszka Szala
Agnieszka Szala
ASAnna Sokolowska
Anna Sokolowska
GMGrazyna Mierzwa
Grazyna Mierzwa
MCMieczyslawa Czerwionka-Szaflarska
Mieczyslawa Czerwionka-Szaflarska
Maciej CedzyńskiMaciej Cedzyński
Maciej Cedzyński
Objective. The incidence of inflammatory bowel disease (IBD) in Europe has increased significantly. At least a fourth of patients are children. Mannan-binding lectin (MBL) is believed to be an important component of innate immunity, acting as an opsonin and activator of the lectin pathway (LP) of complement. The data relating any of the LP factors to IBD are sparse and contradictory and were obtained mainly from adult patients. The aim of this study was to investigate the possible role of MBL in Crohn's disease (CD) and ulcerative colitis (UC) in children. Methods. MBL2 gene single nucleotide polymorphisms (PCR-RFLP) and MBL concentrations (ELISA) were determined. Results. The frequency of MBL2 gene variants responsible for MBL deficiency (LXPA/O and O/O) is significantly higher in CD patients compared with controls or children with UC. A relatively high frequency of the codon 52 mutation (D allele) was noted in these patients. Practically no difference was found between UC and control (C) groups. Similarly, the average MBL levels as well as the number of MBL-deficient (MBL concentrations < 150 ng/ml) individuals differed between CD patients and controls or children suffering from UC. Again, there was no difference between UC and C groups. Conclusions. These data suggest that MBL deficiency may be associated with CD but not with UC in pediatric patients. The possible role of MBL in IBD requires confirmation in larger series and further investigation of the mechanisms involved.

14 April 2024 in Journal of Health Policy & Outcomes Research
Verified
Journal Article
Closed access
SKSylwia Koltan
Sylwia Koltan
Jarek BaranJarek Baran
Jarek Baran
KBKatarzyna Bąbol-Pokora
Katarzyna Bąbol-Pokora
RBRafal Becht
Rafal Becht
EBElżbieta Berdej-Szczot
Elżbieta Berdej-Szczot
MPMalgorzata Pac
Malgorzata Pac
The dynamic development of clinical immunology in Europe began in mid 1980s, and was continued in Poland shortly thereafter. In 1993 the first national consultant in the field of clinical immunology was appointed in Poland. A milestone was the establishment of the Polish Working Group for Primary Immunodeficiencies (PGR for PID) in 2005. Since then, a network of numerous paediatric and internal medicine centres has been created within the Group, facing and resolving new challenges in the field. The study presents the organization of care for patients with primary and secondary immunodeficiencies in Poland, analyzes the staffing situation and patients' access to diagnostics and treatment between late 1980’s and 2024. The summary presents the achievements resulting in improved diagnostic efficiency, shortening the delay in the diagnosis of Inborn Errors of Immunity (IEI)/primary immunodeficiencies (PID), and better access of patients to therapy within drug programs, largely carried out at home. The causes hindering the development of specialization are also analyzed. The most important among them are the lack of systemic support on the part of medical care organizers and the lack of motivation of young doctors to pursue specialization. The main goal is to improve diagnostic and therapeutic procedures for PID patients, including newborn screening, highly specialized, genetic test regardless where they are implemented. It can be only achieved with their better financing. An essential problem is the lack of an epidemiological or clinical IEI registry.

5 July 2024 in Pediatria i Medycyna Rodzinna
Verified
Journal Article
Open access
PDF file
KMKatarzyna Mikołajczyk
Katarzyna Mikołajczyk
AOAgata Joanna Ordon
Agata Joanna Ordon
AKAnna Kuc
Anna Kuc
EMEwa Majda-Stanisławska
Ewa Majda-Stanisławska
KZKrzysztof Zeman
Krzysztof Zeman
Marcin TkaczykMarcin Tkaczyk
Marcin Tkaczyk
Toxoplasmosis, both congenital and postnatally acquired, is a parasitic disease caused by infection with the protozoan Toxoplasma gondii. The most serious manifestation of this disease is congenital toxoplasmosis, resulting from transplacental infection of the foetus during pregnancy. Retinochoroiditis, intracranial calcifications, and hydrocephalus are considered the classic triad of congenital toxoplasmosis. This article describes four cases of severe neurologic and ocular manifestations in paediatric patients diagnosed with toxoplasmosis. The main aim was to examine the nature of clinical presentation as well as to emphasise the necessity of properly administered antiparasitic therapy and underline the importance of prenatal screening to reduce the risk of congenital transmission to the foetus.

29 August 2026 in European Journal of Dentistry
Verified
Journal Article
Open access
MŁMarta Łyszczarz
Marta Łyszczarz
AMAgnieszka Moll-Maryńczak
Agnieszka Moll-Maryńczak
SMSylwia Majewska-Beśka
Sylwia Majewska-Beśka
KZKrzysztof Zeman
Krzysztof Zeman
MTMarcin Tkaczyk
Marcin Tkaczyk
The aims of this study were to provide a comprehensive evaluation of the dental status in pediatric patients with 22q11.2 deletion syndrome (22q11.2DS) and to analyze the associations between clinical dental findings, general medical conditions, and oral hygiene habits. The cross-sectional study included 20 children (10 girls, mean age 6.45 years) with a confirmed diagnosis of 22q11.2DS. Each child underwent a detailed dental examination, including caries (dmft/DMFT: decayed, missing, and filled teeth index for primary and permanent teeth), developmental defects of enamel (DDE), hypodontia, occlusal relationship disorder, and soft tissue findings assessment. Additionally, the functioning of the oral cavity, especially speech and swallowing patterns, was evaluated. Dental findings were correlated with medical history, oral hygiene habits, and laboratory results, with a specific focus on calcium-phosphate metabolism and immunological parameters. Categorical variables were reported as counts and percentages, while continuous variables were presented as medians and interquartile ranges. Nonparametric methods, including Fisher's exact test and the Mann–Whitney U test, were used for group comparisons. Correlations were assessed using Pearson's (r) and Spearman's rank correlation coefficients. All tests were two-tailed with a significance level of α = 0.05. DDE were identified in 13 (65%) children, of whom 6 (30%) were presented with only hypomineralization, 4 (20%) exhibited only hypoplasia, and 3 (15%) demonstrated both defects. Caries prevalence was 70%, with a mean dmft of 4.65 (standard deviation [SD] 5.05) and DMFT of 8.6 (SD 5.77). Occlusal relationship disorders were observed in 11 (55%) children and hypodontia in 3 (15%) children. Age was the most significant variable associated with caries experience (r = 0.73, p < 0.001), while dysmorphic features were the only significant factor for DDE (p = 0.022). No significant correlations were found between dental findings and laboratory parameters or oral hygiene habits. The most common dental manifestations of 22q11.2DS are DDE, dental caries, and oral dysfunctions. No direct correlation was found between oral health and immunological status or calcium-phosphorus metabolism. Caries is a significant problem and more dependent on age than on oral hygiene alone. Patients require early, comprehensive, and coordinated care from dentists, orthodontists, and speech-language pathologists.

23 March 2023 in Medycyna Ogólna i Nauki o Zdrowiu
Verified
Journal Article
Open access
AGAneta Gwozdowska
Aneta Gwozdowska
Kinga PolanskaKinga Polanska
Kinga Polanska
ESEwa Starostecka
Ewa Starostecka
KZKrzysztof Zeman
Krzysztof Zeman
KGKamil Gwozdowski
Kamil Gwozdowski
LBLeokadia Bąk-Romaniszyn
Leokadia Bąk-Romaniszyn
Introduction and objective: Overweight and obesity in children and adolescents has been one of the major health and social challenges worldwide for several decades. Obesity is a multifactorial disease in which the risk factors may appear with various severity and combinations. The aim of the...

1 October 2021 in European Heart Journal
Verified
Journal Article
Open access
PDF file
IJIzabela Jatczak‐Pawlik
Izabela Jatczak‐Pawlik
JLJoanna Lewek
Joanna Lewek
ECE Czkwianianc
E Czkwianianc
KZK Zeman
K Zeman
PJPiotr Jankowski
Piotr Jankowski
TSthe LATE-COVID-Kids study.
the LATE-COVID-Kids study.
Background: Unfortunately, the number of children with the pediatric inflammatory multisystem syndrome (PIMS) associated with previous coronavirus disease has been increasing significantly. Purpose: The aim of the present study was to characterize biochemical and cardiovascular predictors of PIMS risk in children recovered from COVID-19 based on the data from the LATE-COVID-Kids study (NCT04799444). Methods: 131 consecutive COVID-19 convalescents (mean age: 8.89±4.91; 67 boys and 64 girls) hospitalized for the clinical evaluation after the acute phase of the COVID-19 were classified into two groups related to symptoms: 29 children finally diagnosed with PIMS and 102 children with no-PIMS. All patients had confirmed coronavirus infection based on the positive results of nucleic acid test (RT-PCR - reverse transcriptase-polymerase chain), and they were serologically tested for antibodies against SARS-CoV-2. They had detailed laboratory testing, electrocardiography, and echocardiography. Results: The time from COVID-19 recovery was from 1 to 10 months (median 4.0 [3.00–5.00] months). Children with PIMS were significantly younger in comparison to those without (6.60±4.50 vs 9.50±4.80 years, respectively; p=0,005). In comparison to non-PIMS group, children with PIMS had higher level of antithrombin III (111±7.23 vs. 104±10.9; p=0.0015), CK-MB (29.0 [18.5–36.0] vs. 21.0 [15.0–30.7]; p=0.03) and heart rate [HR]/min (100 [89.0–112] vs. 90.0 [79.0–100]; p=0.006) but lower PQ interval (120 [110–120] vs. 130 [120–140]; p=0.023) on admission to hospital. Moreover, the immunological parameters: IgA and neutrophils were lower in children with PIMS vs. no-PIMS (0.69 [0.47–0.85] vs. 1.19 [0.71–1.50]; p=0.0001 and 37.4%±13.3 vs. 43.0±11.6; p=0.0045, respectively), but lymphocytes were significantly higher (50.6±13.6 vs. 43.7±10.9; p=0.002). Some acid-base balance parameters were higher in children following PIMS vs. no-PIMS children group: pCO2 (41.30±5.70 vs. 45.0±7.00; p=0.019), pO2 (50.1 [38.4–59.7] vs. 37.8 [27.9–49.9]; p=0.007), and O2Sat (84.2 [69.3–90.6] vs. 64.2 [44.3–82.6]; p=0.004); however, concentration of HCO3- (23.6 [22.2–24.4] vs. 24.3 [22.8–26.2]; p=0.023) was lower in group of PIMS children. Conclusions: Based on our best knowledge, it is the first data on the possible predictors of PIMS risk in children recovered from COVID-19. We showed that children with PIMS have significantly higher levels of antithrombin III, CK-MB, HR, as well as lymphocytes, pCO2, pO2 and O2Sat on admission to hospital and lower levels of PQ interval, IgA, neutrophils and concentration of HCO3. We continue our research to confirm these results and to create the PIMS SCORE algorithm to allow prediction of children with the risk of PIMS occurrence after COVID-19 recovery. Funding Acknowledgement: Type of funding sources: None.